|
FLT3 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.232360E-02 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.397600E-02 |
| Normal-vs-Stage2 |
6.036400E-04 |
| Normal-vs-Stage3 |
9.478400E-03 |
| Normal-vs-Stage4 |
2.763700E-02 |
| Stage1-vs-Stage2 |
2.97150000050372E-07 |
| Stage1-vs-Stage3 |
2.490000E-01 |
| Stage1-vs-Stage4 |
7.596400E-01 |
| Stage2-vs-Stage3 |
2.360300E-04 |
| Stage2-vs-Stage4 |
5.278400E-02 |
| Stage3-vs-Stage4 |
7.458400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.185700E-02 |
| Normal-vs-AfricanAmerican |
1.620090E-03 |
| Normal-vs-Asian |
1.355540E-02 |
| Caucasian-vs-AfricanAmerican |
7.405500E-04 |
| Caucasian-vs-Asian |
5.048800E-01 |
| AfricanAmerican-vs-Asian |
6.460000E-02 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.332300E-02 |
| Normal-vs-Female |
9.598900E-03 |
| Male-vs-Female |
4.758800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.181800E-02 |
| Normal-vs-Age(41-60Yrs) |
6.122300E-03 |
| Normal-vs-Age(61-80Yrs) |
7.195100E-03 |
| Normal-vs-Age(81-100Yrs) |
2.013200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.197800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.239770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.084400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.389800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.937760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.269800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.955400E-01 |
| Classical-VS-Follicular |
3.71949999999899E-05 |
| Classical-VS-Other |
1.729520E-02 |
| Classical-VS-Normal |
2.291500E-02 |
| Tall-VS-Follicular |
3.034400E-02 |
| Tall-VS-Other |
1.185000E-01 |
| Tall-VS-Normal |
3.302200E-02 |
| Follicular-VS-Other |
4.007600E-01 |
| Follicular-VS-Normal |
1.139780E-03 |
| Other-VS-Normal |
2.776700E-03 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.360600E-03 |
| Normal-vs-N1 |
4.183500E-03 |
| N0-vs-N1 |
6.391000E-01 |
|
|
